के सभी प्रकाशन Vaibhav Warade . पुणे , भारत

Artificial Cervical Disc Market Growth Top Key Players Review 2022 | Fast Forward Research

Artificial Cervical Disc Market

The global Artificial Cervical Disc Market is driven by several factors, such asthe increasing prevalence of orthopedic diseases and degenerative diseases, technological advancements in artificial discs, and the rise of a geriatric population in developed and developing economies.

According to MRFR analysis, the global Artificial Cervical Disc Market Growth is expected to register a CAGR of ~19% and hold a value of ~USD 6,262.1 million by 2027.

In addition, the Artificial Cervical Disc Market is anticipated to grow during the forecast perioddue to the rising healthcare expenditure, supportive reimbursement, growing acceptance of implantation, increasing disposable income, and increasing investments in healthcare infrastructure by the government and private sectors.

Major Key Players:

Some of the key players in the global Artificial Cervical Disc Market F are Globus Medical Inc (US), Zimmer Biomet Holdings Inc. (US), B. Braun Melsungen AG (Germany), Centinel Spine, LLC (Switzerland), Medtronic PLC (Ireland), Nuvasive Inc. (US), Johnson & Johnson (US), Orthofix Company (US), Alphatec Spine (US), Simplify Medical (US), AxioMed (US), Aditus Medical (Germany), FH Orthopedics (France), Medicrea (France), and Spineart (Switzerland)

Segment Analysis

The artificial cervical disc market is segmented on the basis of artificial cervical disc types, material, end user, and region.

Based on product type, the artificial cervical disc market is categorized into cervical disc and lumbar disc. The cervical disc segment held a significant market share in 2020.The rising prevalence of degenerative disc disease and the growing demand for non-invasive procedures are the key driving factors of the artificial cervical disc segment.

Based on material, the artificial cervical disc market is classified into metal-on-metal and metal-on-biopolymer. The metal-on-metal material segment is expected to attain significant revenue over the forecast period. Growing preference for metal implants by Numerous healthcare practitioners, including surgeons, doctors, and clinicians.Moreover, metal implants requires considerably lower costs than metal-on-biopolymers.

Based on enduser, the artificialcervical disc market can be segmented into hospitals, ambulatory surgical centers, and others. The hospitals segment was the largest end usersegment in 2020 due to the availability of skilled doctors, high efficacy rate, better treatment, and advancements in the hospital infrastructure.

In terms of geography, the artificialcervical disc market has been segmented into North America, Europe, Asia-Pacific, and the Rest of the World.North America held the largest market share in 2020 due to the increasing geriatric population, higher success rate of artificial disc replacement surgery in this region, and growing awareness among the patients about the availability of various treatment options. Furthermore, Asia-Pacific is projected to be the fastest-growing regional market during the forecast period due to factors such as a large customer base, high prevalence of orthopedic diseases, degenerative spine conditions, and improving healthcare infrastructure.According to the WHO, by 2050, 130 million people will suffer from osteoarthritis worldwide, of whom 40 million will be severely disabled by the disease.

Regional Analysis

On a regional basis, North America is anticipated to dominate theglobal Artificial Cervical Disc Market due tothe major market players involved in R&D activity,a higher success rate of artificial disc replacements, rising healthcare expenditurein the region, and improving economy.In addition, the presence of the major giants in the market involved in merger &acquisition and new product innovation is another driving the market growth. For instance,in January 2018, Nuvasive Inc. (US)acquired Safe PassageNeuromonitoring LLC(US)to strengthen its intraoperative neurophysiological monitoring (IONM) business line.

On the other hand, Europe is expected to hold the second-largest position in the global Artificial Cervical Disc Market due to investment in healthcare.Technological advancements in surgical techniques and materials have led to an increased demand for artificial cervical disc.

Furthermore, artificial cervical disc replacement in Europe will turn out to be one of the most sought-after medical procedures by medical tourists. Cost-effective and excellent medical care offered by the European spine surgeons and increasing investment in the R&D sector isalso fueling the market growth in this region.

Asia-Pacificis projected to have the fastest growth, owing to a rapidly developing medical infrastructure, increasing spending on health care, large population, improving economy, and growing medical tourism in developing nations such as China, Japan, and India in this region.

Furthermore, the growth of the market in theRest of the World is attributed to rapidly improving healthcare infrastructure, technological development,healthcare management, and hospital management.Government initiatives for improving the healthcare sector are another factor boosting the growth of the market in this region.

About Market Research Future

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 646 845 9312

Email: [email protected]

Menopause Treatment Market Outlook, Opportunities, Top Key Players and Forecast to 2027

Menopause Treatment Market Growth

Menopause causes uncomfortable symptoms, such as hot flashes, vaginal dryness, and weight gain and menopause treatments such as hormonal and non-hormonal treatments help to relieve these symptoms. Over the years, major market players in the menopause treatment are focusing on various growth strategies such as product launches, product advancements, and expansions to cater to the growing needs for patients seeking treatment for menopause symptoms.

For instance, in April 2019, Otsuka Pharmaceutical launched EQUELLE, a non-prescription, non-hormonal supplement to alleviate the frequency of hot flashes and muscle aches associated with menopause in the US. Such strategies push the demand for branded as well as generic menopausal drugs, thus promising huge growth for the industry.

Global Menopause Treatment Market Growth is expected to have a market value of USD 15,456.3 Million by 2027.

Major Key Players:

MRFR recognizes the following companies as the Key Players in the Global Menopause Treatment Market— Novo Nordisk A/S (Denmark), Pfizer Inc. (US), Allergan (Ireland), Eli Lily and Company (US), Emcure Pharmaceuticals Ltd (India), Novartis AG (Switzerland), Cipla Inc. (India), Teva Pharmaceuticals (Israel), Merck & Co., Inc. (US), Abbott Laboratories (US).

Segment Analysis

The global menopause treatment market is segmented based on treatment and distribution channel.

The global menopause treatment market based on the treatment has been segmented into hormonal treatment and non-hormonal treatment. The hormonal treatment segment is further segmented into estrogen, progesterone, and combination. The non-hormonal treatment is further segmented into anti-depressants and others.

Based on distribution channel, the menopause treatment market is segmented into hospital pharmacies, retail pharmacies, and online stores.

Regional Analysis

The global menopause market, based on region, has been divided into the Americas, Europe, Asia-Pacific, and Middle East & Africa.

The Americas has been segmented into North America and Latin America, with the North America market further divided into the US and Canada. The Americas led the market and accounted for the largest share in 2019 owing to the increasing product approvals and high uptake of new technology. For instance, in July 2017, AMAG Pharmaceuticals, Inc. (US) launched Intrarosa (prasterone) for the treatment of moderate to severe dyspareunia a symptom of vulvar and vaginal atrophy (VVA), due to menopause. Thus, such strategies employed by major players aid in the increased growth rate for the Americas menopause treatment industry.

The European menopause treatment market has been further segmented into Western Europe and Eastern Europe. The Western Europe menopause treatment market has further been classified into Germany, France, the UK, Italy, Spain, and the rest of Western Europe. Europe follows the Americas in the global menopause treatment market. The increasing inclination of companies towards female technology (femtech) is boosting the growth of the menopause treatment market in European countries. Many digital health start-ups have identified this opportunity and are offering B2C digital health tools, such as mobile apps, to guide menopausal women through this phase with lifestyle intervention tips and online telehealth consultations. As a result, the region is expected to show significant growth in the menopause treatment market.

The menopause treatment market in Asia-Pacific has been segmented into China, India, Japan, South Korea, Australia, and the rest of Asia-Pacific. Asia-Pacific is expected to register the highest growth rate over the forecast period from 2020 to 2027. This is owing to the growing penetration of the women’s health sector, increasing awareness about the betterment of the women’s health, and the growing number of educational campaigns related to the benefits of hormone replacement therapy in China, Japan, India, and Australia.

The Middle East & Africa menopause treatment market is segmented Saudi Arabia, the United Arab Emirates (UAE), Oman, Kuwait, Qatar, and the rest of the Middle East & Africa. The negative connotation of menopause has resulted in a negative attitude towards menopause in premenopausal women. However, with the increasing awareness created by private companies, the scenario is expected to change in the next ten years.

About Market Research Future

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 646 845 9312

Email: [email protected]

Global Antibiotic Resistance Market Insights 2022 Share, Size, Trend, Analysis and Forecast to 2027

Antibiotic Resistance Market Insights

Antimicrobial resistance occurs when microorganisms such as bacteria, viruses, fungi, and parasites change when they are exposed to antimicrobial drugs. Antibiotic drugs include antibiotics, antifungals, antivirals, antimalarials, and anthelmintic.

According to MRFR analysis, Antibiotic Resistance Market Insights is expected to register a CAGR of 5.8% and was valued at USD 8,120 Million in 2018.

The growth of global Antibiotic Resistance Market is driven by various factors such as - Rising antibiotic drug resistance infections, rise in the incidence of chronic and infectious disease, increase in clinical developments of antibiotic resistance, and rise in global initiatives to control drug-resistance

Several market players currently dominate the global Antibiotic Resistance Market. The key players are involved in product launches and strategic collaborations to strengthen their market positions.

Major Key Players:

Some of the Key Players in the Global Antibiotic Resistance Market are Achaogen, Inc. (US), MELINTA THERAPEUTICS, INC. (US), Nabriva Therapeutics plc (Ireland), PARATEK therapeutics (US), Seres Therapeutics (US), Theravance Biopharma (UK), Tetraphase Pharmaceuticals (US), Basilea Pharmaceutica Ltd. (Switzerland), Entasis Therapeutics (US), NEMESIS BIOSCIENCE LTD (UK), Procarta Biosystems (England), and Allecra Therapeutics (US)

Segment Analysis

The Global antimicrobial resistance market has been Segmented Based on Drug Class, Disease, Pathogen, and End User.

The market, based on drug class, has been divided into cephalosporins, Combination therapies, tetracyclines, lipoglycopeptides, oxazolidinones, and others. The combination therapies segment is likely to be the largest growth during the review period due to the increased usage of these therapies for gram-negative infections. Additionally, it has minimal treatment options available with the increasing demand for antibiotic resistance, thus driving the growth of this segment.

The global Antibiotic Resistance Market has been bifurcated, based on disease, into complicated urinary tract infections, bloodstream infections, complicated intra-abdominal infections, clostridium difficile infections, acute bacterial and skin structure infections, hospital-acquired bacterial pneumonia/ventilator, community-acquired bacterial pneumonia, and others. The complicated urinary tract infections segment is expected to hold the majority share of the market as urinary tract infections (UTIs) are one of the most common types of infections. Additionally, there were around 1,045 patients affected by UTI.

The global Antibiotic Resistance Market has been segmented based on pathogen into staphylococcus aureus, streptococcus pneumoniae, acinetobacter, enterococcus, Hemophilus influenzae, pseudomonas aeruginosa, clostridium difficile, K. pneumoniae, campylobacter, and others. K. pneumoniae is expected to be the fastest segment owing to the increasing K. pneumoniae. Moreover, there were around 212,500 infection cases per year and about 70 deaths every year which would eventually drive the growth of the antibiotic market in this segment.

The end user segment of the Antibiotic Resistance Market includes hospitals & clinics, research organizations, and others. The hospitals & clinics segment is expected to hold the largest share of the market as the majority of treatments and procedures are carried out in hospitals, which ultimately increases the usage of antibiotic resistance drugs in the Antibiotic Resistance Market. As a result, this drives the growth of the Antibiotic Resistance Market.

Regional Analysis

The market has been divided, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The Americas is expected to be the largest market owing to the rising growth in the pharmaceutical sector. The Antibiotic Resistance Market in the Americas has further been branched into North America and Latin America, with the North American market divided into the US and Canada. The European Antibiotic Resistance Market has been categorized as Western Europe and Eastern Europe. The Western European market has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. The Antibiotic Resistance Market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. Increasing healthcare expenditure has boosted the growth of the Antibiotic Resistance Market; the market in Asia-Pacific is expected to be the fastest-growing. The Antibiotic Resistance Market in the Middle East & Africa has been divided into the Middle East and Africa.

About Market Research Future

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 646 845 9312

Email: [email protected]